Amaç: Beyin omurilik sıvısı bileşiminin normal olması ve intrakraniyal yer kaplayıcı lezyon veya hidrosefali gibi yapısal bir lezyonun olmaması ile ortaya çıkan kafa içi basıncının artışı, psödotümör serebri sendromu (PTS) olarak kabul edilmektedir. Bu çalışmada, PTS tanısı ile izlenen hastaların klinik, nörooftalmolojik ve demografik özelliklerinin incelenmesi amaçlanmıştır. Gereç ve Yöntemler: Ankara Eğitim ve Araştırma Hastanesi Göz Kliniği Nörooftalmoloji Biriminde, Haziran 2016-Haziran 2018 tarihleri arasında başvuran PTS tanılı hastalar retrospektif olarak incelendi. Hastaların tüm nörooftalmolojik muayeneleri, bilgisayarlı görme alanı, optik koherens tomografi ve magnetik rezonans görüntüleme (MRG) bulguları değerlendirildi. Bulgular: PTS tanısı almış 54 hastanın 108 gözü incelendi. Hastaların 48 (%88,9)'si kadın, 6 (%11,1)'sı erkekti. Ortalama yaş 32,5 ± 11,6 yıl idi. Baş ağrısı ile 31 (%57,4), geçici görme kaybı ile 10 (%18,5), rutin göz muayenesi sırasında 9 (%16,7), çift görme ile 3 (%5,6), kulak uğultusu ile 1 (%1,9) hasta başvurmuştu. Yeni tanı almış 24 hastanın 21 (87,5)'inde papil ödem saptandı, 3 (%12,5)'ünde papil ödem yoktu. Hastaların tümüne bakıldığında; 4 (%7,4)'ünde optik disk druseni (ODD) ile birlikte papil ödem, 1'inde iki gözün 6 yıl ara ile etkilendiği tespit edildi. Hastaların tümüne medikal tedavi uygulandı. Olguların 49 (%90,7)'u asetazolamidden yarar gördü. Medikal tedaviye yanıt vermeyen 5 (%9,3) hastaya cerrahi planlandı. Hastaların 4 (%7,4)'üne ventriküloperitoneal şant, 1 (%1,9)'ine optik sinir kılıf fenestrasyonu uygulandı. Sonuç: Çalışmamızda; PTS'li hastaların yarısında oftalmolojik semptomlar ile tanıya gidildiği tespit edilmiştir. Bu nedenle rutin oftalmolojik muayenede fundus değerlendirilmesi önemlidir. Bu çalışmada, hastaların yaklaşık yarısında MRG'nin normal olabileceği, tek taraflı papil ödem, papil ödemsiz ve ODD ile papil ödem hastalarının görülebileceğini vurgulamak istedik. Bu klinik bulgular tespit edilen hastalarda ön tanıda PTS akılda tutulmalıdır. Uygun ve zamanında tanı ve tedavi ile görme kayıplarının önüne geçilebilir.
Anahtar Kelimeler: Psödotümör serebri; demografi; papil ödem
Objective: Pseudotumor cerebri syndrome (PTCS) is increased intracranial pressure with normal cerebrospinal fluid composition and absence of a structural lesion such as intracranial space-occupying lesion or hydrocephalus. This study aimed to investigate the clinical and demographic characteristics of patients with PTCS. Material and Methods: A retrospective analysis of PTCS was performed between June 2016-June 2018 in the Neuro-Ophthalmology Unit of Ankara Training and Research Hospital Eye Clinic. All ophthalmologic examinations, visual field, optical coherence tomography (OCT) and magnetic resonance (MR) findings were evaluated. Results:108 eyes of 54 PTCS patients were assesmented. 48 (88.9%) patients were female and 6 (11.1%) patients were male. The mean age was 32.5 ± 11.6. 31 (57.4%) patients had headache, 10 (18.5%) had transient vision problem, 9 (16.7%) had in routine ophthalmologic examination, 3 (5.6%) had double vision and 1 (1.9%) patient had tinnitus. 24 patients had new diagnosed for PTCS; 21 (87.5%) with papilledema, and 3 (12.5%) without papilledema. In all patients; 4 (7.4%) patients had optic disc drusen (ODD) and papilledema together. All patients were treated. 49 (90.7%) of the cases were in remission with acetazolamide. Five (%9.3) patients who did not respond to medical treatment were undergone surgery. Ventriculoperitoneal shunt was applied to 4 (7.4%) patients, and optic nerve sheath fenestration was applied to 1 (1.9%) patient. Conclusion: The goals of this study; in almost half of the patients with PTCS were diagnosed in routine ophtalmologic examination with ophtalmologic symptoms, and MRI can be normal half of the patients, unilateral papilledema, without papilledema and papilledema with ODD cases can be seen. PTCS should be thought in case of these clinical findings were seen. Loss of vision can be prevented by proper and timely diagnosis and treatment.
Keywords: Pseudotumor cerebri; demography; papilledema
- Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59(10):1492-5. [Crossref] [PubMed]
- Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An update review of mechanism and treatment. Cephalalgia. 2006;26(4):384-99. [Crossref] [PubMed]
- Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumour cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988;45(8):875-7. [Crossref] [PubMed]
- Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: mechanism, manangement, and future directions. Lancet Neurol. 2016;15(1):78-91. [Crossref]
- Kosmorsky GS. Idiopathic intracranial hypertension: pseudotumor cerebri. Headache. 2014;54(2):389-93. [Crossref] [PubMed]
- Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988;45(8):875-7. [Crossref] [PubMed]
- Asensio-Sánchez VM, Merino-Angulo J, Martínez-Calvo S, Calvo MJ, Rodríguez R. [Epidemiology of pseudotumor cerebri]. Arch Soc Esp Oftalmol. 2007;82(4):219-21. [Crossref] [PubMed]
- Yri HM, Wegener M, Sander B, Jensen R. Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol. 2012;259(5):886-94. [Crossref] [PubMed]
- Arslan D, Arıkanoglu A, Akıl E. [Clinical and demographic features of pseudotumor cerebri syndrome diagnosed in a university hospital]. Turk J Neurol. 2017;23(2):60-3. [Crossref]
- Kesler A, Fattal-Valevski A. Idiopatic intracranial hypertension in the pediatric population. J Child Neurol. 2002;17(10):745-8. [Crossref] [PubMed]
- Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2014;32(2):363-96. [Crossref] [PubMed]
- Lipton HL, Michelson PE. Pseudotumor cerebri syndrome without papilledema. JAMA. 1972;220(12):1591-2. [Crossref]
- Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology. 1998;51(1):245-9. [Crossref] [PubMed]
- Bridges KJ, Raslan AM. Utility of intracranial pressure monitoring for diagnosis of idiopathic intracranial hypertension in the absence of papilledema. World Neurosurg. 2018;111(3): e221-7. [Crossref] [PubMed]
- Birnbaum FA, Johnson GM, Johnson LN, Jun B, Machan JT. Increased prevalence of optic disc drusen after papilloedema from idiopathic intracranial hypertension: on the possible formation of optic disc drusen. Neuroophthalmology. 2016;40(4):171-80. [Crossref] [PubMed] [PMC]
- Ibrahimov E, Selver OB, Ozturk AT, Yaman A, Bajin MS, Saatci AO. [Evaluation of retinal nerve fiber layer thickness in swollen optic disc]. Ret-Vit. 2010;18(1):154-8.
- Pro MJ, Pons ME, Liebmann JM, Ritch R, Zafar S, Lefton D, et al. Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis. J Neurol Sci. 2006;250(1-2):114-9. [Crossref] [PubMed]
- Albrecht P, Blasberg C, Ringelstein M, Müller AK, Finis D, Guthoff R, et al. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol. 2017;264(7):1370-80. [Crossref] [PubMed]
- Vartin CV, Nguyen AM, Balmitgere T, Bernard M, Tilikete C, Vighetto A. Detection of mild papilloedema using spectral domain optical coherence tomography. Br J Ophthalmol. 2012;96(3):375-9. [Crossref] [PubMed]
- Brodsky MC, Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology. 1998;105(9):1686-93. [Crossref]
- Ridha MA, Saindane AM, Bruce BB, Riggeal BD, Kelly LP, Newman NJ, et al. MRI findings of elevated intracranial pressure in cerebral venous thrombosis versus idiopathic intracranial hypertension with transverse sinus stenosis. Neuroophthalmology. 2013;37(1):1-6. [Crossref] [PubMed] [PMC]
- Brodsky MC, Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology. 1998;105(9):1686-93. [Crossref]
- Akçakaya NH, Akçakaya MO, Sencer A, Yapıcı Z. [Idiopathic intracranial hypertension: diagnosis and therapeutic approach]. Turk J Neurol. 2017;23(2):43-50. [Crossref]
- Julayanont P, Karukote A, Ruthirago D, Panikkath D, Panikkath R. Idiopathic intracranial hypertension: on going clinical challenges and future prospects. J Pain Res. 2016;9(2):87-99. [Crossref] [PubMed] [PMC]
- Per H, Canpolat M, Gümüş H, Poyrazoğlu HG, Yıkılmaz A, Karaküçük S, et al. Clinical spectrum of the pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis. Brain Dev. 2013;35(6):561-8. [Crossref] [PubMed]
- Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114(Pt 1A):155-80.
- Yuksel D, Altiparmak UE, Aslan BS, Duman S. [Bilateral optic nerve sheath decompression in pseudotumor cerebri with chronic papilledema: case report]. Turk J Ophthalmol. 2007;37(5):381-4.
.: Process List